Comparative Analysis of Robotic Segmentectomy For Non-Small Cell Lung Cancer: A National Cancer Database Study
Karishma Kodia1, Syed S Razi2, Ahmed Alnajar1
11584247824 Division of Thoracic Surgery, University of Miami Hospital, FL, USA.
Innovations (Philadelphia, Pa.)
|April 19, 2021
Summary
Robotic segmentectomy offers comparable outcomes to VATS and open surgery for early-stage lung cancer. While robotic approaches yield more lymph nodes, this did not translate to improved survival in the study.
Area of Science:
- Thoracic Surgery
- Surgical Oncology
- Minimally Invasive Surgery
Background:
- Segmentectomy is increasingly used for early-stage non-small cell lung cancer (NSCLC).
- Comparing robotic, video-assisted thoracoscopic surgery (VATS), and open approaches is crucial for optimizing treatment.
Purpose of the Study:
- To compare clinical outcomes and overall survival.
- Evaluate robotic, VATS, and open segmentectomy for T ≤2 cm, N0 NSCLC.
Main Methods:
- Analysis of the National Cancer Database (2010-2015).
- Inclusion of patients with T ≤2 cm, N0 NSCLC undergoing segmentectomy.
- Comparison of robotic, VATS, and open approaches using univariate and Cox regression analyses.
Main Results:
- Robotic segmentectomy showed a higher lymph node yield (median 6) versus VATS (5) and open (4).
- Shorter length of stay was observed for robotic compared to open surgery.
- No significant differences in 30-day readmissions or overall survival were found among the three approaches.
Conclusions:
- Robotic segmentectomy is a viable option with similar clinical outcomes to VATS and open surgery for early-stage NSCLC.
- Increased lymph node yield with robotic surgery did not correlate with improved survival in this cohort.
